Amcad Biomed CorporationTPEX: 4188

On behalf of our subsidiary Broadsound Co., we announce the major resolutions of 2022 Annual General Shareholders' Meeting.

· Issued by AmCad BioMed Corporation
Close
Today's Information

Provided by: AmCad BioMed Corporation
SEQ_NO 1 Date of announcement 2022/06/09 Time of announcement 16:03:21
Subject
 On behalf of our subsidiary Broadsound Co.,
we announce the major resolutions of 2022 Annual General
Shareholders' Meeting.
Date of events 2022/06/09 To which item it meets paragraph 18
Statement
1.Date of the shareholders' meeting:2022/06/09
2.Important resolutions  I.Profit distribution/deficit compensation:
Adoption 2021 loss be subsidized, and in the case of capital
reserves to make up for the accumulated losses:Approved.
3.Important resolutions II.Amendments of the company charter:None.
4.Important resolutions III.Business report and financial statements:
Recognized 2021 Business Report and Financial Statements.
5.Important resolutions IV.Election for directors and supervisors:None.
6.Important resolutions V.Other matters:None.
7.Any other matters that need to be specified:None.

Company analysis

Earlier from Amcad Biomed

All Amcad Biomed news releases